Company Filing History:
2 out of 155 
2 out of 23 
Years Active: 2017-2020
Title: Sonja Kern: Innovator in Cancer Research
Introduction
Sonja Kern is a prominent inventor based in Wuerzburg, Germany. She has made significant contributions to the field of cancer research, particularly in the therapeutic use of parvoviruses. With a total of 2 patents, her work focuses on innovative approaches to eliminate cancer stem cells.
Latest Patents
Sonja Kern's latest patents include the use of parvovirus for eliminating cancer stem cells (CSCs). This patent describes the application of a parvovirus, preferably H-1PV, for the therapeutic elimination of cancer stem cells, specifically targeting neuroblastoma stem cells and glioblastoma stem cells. This groundbreaking research holds promise for advancing cancer treatment methodologies.
Career Highlights
Throughout her career, Sonja Kern has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. Her dedication to cancer research has positioned her as a key figure in the scientific community, contributing to advancements in understanding and treating cancer.
Collaborations
Sonja has collaborated with notable coworkers, including Jean Rommelaere and Jeannine Lacroix. These partnerships have further enriched her research and expanded the impact of her work in the field of cancer therapy.
Conclusion
Sonja Kern's innovative research and patents in the use of parvoviruses for cancer treatment exemplify her commitment to advancing medical science. Her contributions are paving the way for new therapeutic strategies in the fight against cancer.